J. A. Clegg

Antagonists of the Platelet P<i>_2T</i> Receptor:  A Novel Approach to Antithrombotic Therapy

Anthony H. Ingall, John Dixon, Andrew Bailey et al. · Journal of Medicinal Chemistry · 1999 · 285 citations

Antithrombotic Therapy, Novel Approach, Pharmacotherapy +17

Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial

Adam B. Greenbaum, Cindy L. Grines, John A. Bittl et al. · American Heart Journal · 2006 · 216 citations

Thrombosis, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention +11

A phase I/II study of trichosanthin treatment of HIV disease

Vera S. Byers, Alan S. Levin, Larry A. Waites et al. · AIDS · 1990 · 117 citations

Carrier design: biodistribution of branched polypeptides with a poly(L-lysine) backbone

J. A. Clegg, Ferenc Hudecz, Gábor Mező et al. · Bioconjugate Chemistry · 1990 · 50 citations

Pharmacological profile of the novel P₂T‐purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo

Robert G. Humphries, Wendy Tomlinson, J. A. Clegg et al. · British Journal of Pharmacology · 1995 · 49 citations · Full text

Fold Selectivity, Neuropeptides, Fpl 67085 +19